| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Joshua A Hill | Q57056017 |
| P2093 | author name string | Danielle M Zerr | |
| P2860 | cites work | Update on human herpesvirus 6 biology, clinical features, and therapy | Q24557543 |
| Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2012) | Q28263889 | ||
| The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro | Q28275318 | ||
| Acute hepatitis with periportal confluent necrosis associated with human herpesvirus 6 infection in liver transplant patients | Q28296826 | ||
| Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective | Q28388806 | ||
| HHV-6 reactivation and associated sequelae after hematopoietic cell transplantation | Q28727925 | ||
| HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipients | Q28743914 | ||
| Human herpes 6 virus encephalitis complicating allogeneic hematopoietic stem cell transplantation | Q30604692 | ||
| Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation | Q33342189 | ||
| Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin | Q33897804 | ||
| Human herpesvirus 6 can be detected in cerebrospinal fluid without associated symptoms after allogeneic hematopoietic cell transplantation. | Q34195389 | ||
| Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT. | Q34273968 | ||
| Chromosomal integration of human herpesvirus 6 is the major mode of congenital human herpesvirus 6 infection | Q34596568 | ||
| Identification of chromosomally integrated human herpesvirus 6 by droplet digital PCR. | Q35879617 | ||
| Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation | Q36095851 | ||
| Lymphotropic herpesvirus DNA detection in patients with active CMV infection - a possible role in the course of CMV infection after hematopoietic stem cell transplantation | Q36516712 | ||
| Persistent human herpesvirus-6 infection in patients with an inherited form of the virus | Q37189313 | ||
| Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis. | Q37276889 | ||
| A report of human herpesvirus 6-associated encephalitis in a solid organ transplant recipient and a review of previously published cases | Q37605671 | ||
| Association of HHV-6 and HHV-7 reactivation with the development of chronic allograft nephropathy | Q84004264 | ||
| Foscarnet against human herpesvirus (HHV)-6 reactivation after allo-SCT: breakthrough HHV-6 encephalitis following antiviral prophylaxis | Q84507133 | ||
| Quantitative detection of HHV-6 and HHV-7 in transbronchial biopsies from lung transplant recipients | Q84659926 | ||
| Human herpesvirus-6 encephalitis during hematopoietic stem cell transplantation leads to poor prognosis | Q85918743 | ||
| HHV-6 encephalitis in pediatric unrelated umbilical cord transplantation: a role for ganciclovir prophylaxis? | Q37618303 | ||
| Chromosomally integrated human herpesvirus 6: questions and answers | Q37952634 | ||
| Chromosomally integrated human herpesvirus-6 in transplant recipients | Q37982856 | ||
| HHV-6 encephalitis in umbilical cord blood transplantation: a systematic review and meta-analysis | Q38045704 | ||
| Hepatitis due to human herpesvirus 6B after hematopoietic cell transplantation and a review of the literature. | Q38202288 | ||
| Child and adult forms of human herpesvirus 6 encephalitis: looking back, looking forward | Q38208987 | ||
| Predominant human herpesvirus 6 variant A infant infections in an HIV-1 endemic region of Sub-Saharan Africa | Q38896758 | ||
| Human herpesviruses 6, 7 and 8 in solid organ transplant recipients | Q40259107 | ||
| Human Herpesvirus-6 cytopathic inclusions: an exceptional and recognizable finding on skin biopsy during HHV6 reactivation after autologous stem-cell transplantation | Q40287343 | ||
| Early human herpesvirus type 6 reactivation after allogeneic stem cell transplantation: a large-scale clinical study. | Q40300472 | ||
| Primary HHV 6 infection after liver transplantation with acute graft rejection and multi-organ failure: successful treatment with a 2.5-fold dose of cidofovir and reduction of immunosuppression | Q40363190 | ||
| Human herpesvirus 7 in pediatric hematopoietic stem cell transplantation | Q40483652 | ||
| Human herpesvirus-6 and -7 in pediatric stem cell transplantation. | Q40515277 | ||
| Human herpesvirus 7-associated meningitis and optic neuritis in a patient after allogeneic stem cell transplantation | Q40558451 | ||
| CMV infection is usually associated with concurrent HHV-6 and HHV-7 antigenemia in liver transplant patients | Q40573557 | ||
| Molecular and virological evidence of viral activation from chromosomally integrated human herpesvirus 6A in a patient with X-linked severe combined immunodeficiency | Q42216350 | ||
| Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease | Q42219821 | ||
| CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation | Q42246598 | ||
| Sequence analysis of transplacentally acquired human herpesvirus 6 DNA is consistent with transmission of a chromosomally integrated reactivated virus | Q42275081 | ||
| Calibrated real-time polymerase chain reaction for specific quantitation of HHV-6A and HHV-6B in clinical samples. | Q42275866 | ||
| Human herpesvirus-6 DNAemia is a sign of impending primary CMV infection in CMV sero-discordant renal transplantations. | Q42277189 | ||
| Human herpesvirus 6 in donor biopsies associated with the incidence of clinical cytomegalovirus disease and hepatitis C virus recurrence | Q43047533 | ||
| Plasma HHV-6 viral load-guided preemptive therapy against HHV-6 encephalopathy after allogeneic stem cell transplantation: a prospective evaluation. | Q43537600 | ||
| Human herpesvirus-7 in Brazilian liver transplant recipients: a follow-up comparison between molecular and immunological assays | Q43690887 | ||
| Human herpesvirus 6 limbic encephalitis after stem cell transplantation | Q43798251 | ||
| Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients | Q43843926 | ||
| Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study | Q43971471 | ||
| Long-term outcome of human herpesvirus-6 encephalitis after allogeneic stem cell transplantation | Q44098277 | ||
| Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT. | Q44189939 | ||
| Risk factors and clinical consequences of human herpesvirus 7 infection in paediatric haematopoietic stem cell transplant recipients | Q44775294 | ||
| High intrahepatic HHV-6 virus loads but neither CMV nor EBV are associated with decreased graft survival after diagnosis of graft hepatitis | Q45360416 | ||
| Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome. | Q45394548 | ||
| Influence of ganciclovir prophylaxis on citomegalovirus, human herpesvirus 6, and human herpesvirus 7 viremia in renal transplant recipients | Q46554298 | ||
| Herpesvirus infections in solid organ transplant patients at high risk of primary cytomegalovirus disease | Q46710163 | ||
| Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6. | Q48110777 | ||
| Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient | Q48123460 | ||
| Detection of active human herpesvirus-6 infection in the brain: correlation with polymerase chain reaction detection in cerebrospinal fluid | Q48318086 | ||
| Clinical significance of pretransplant chromosomally integrated human herpesvirus-6 in liver transplant recipients. | Q53243888 | ||
| Preemptive therapy of human herpesvirus-6 encephalitis with foscarnet sodium for high-risk patients after hematopoietic SCT | Q53301048 | ||
| Transmission of integrated human herpesvirus 6 through stem cell transplantation: implications for laboratory diagnosis. | Q53633777 | ||
| HHV-6 variant A meningoencephalitis after allogeneic hematopoietic stem cell transplantation diagnosed by quantitative real-time polymerase chain reaction. | Q54646796 | ||
| PROSPECTIVE STUDY OF HUMAN BETAHERPESVIRUSES AFTER RENAL TRANSPLANTATION | Q57181387 | ||
| Fatal herpesvirus 6 encephalitis after unrelated bone marrow transplant | Q58391723 | ||
| The Complex Relationship between Human Herpesvirus 6 and Acute Graft-versus-Host Disease | Q58415978 | ||
| Human herpesvirus-6 is associated with cytomegalovirus reactivation in liver transplant recipients | Q73670490 | ||
| Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: does it have clinical significance? | Q77292867 | ||
| Human herpesvirus-6 and -7 after lung and heart-lung transplantation | Q79596077 | ||
| An assessment of the effect of human herpesvirus-6 replication on active cytomegalovirus infection after allogeneic stem cell transplantation | Q82224347 | ||
| P304 | page(s) | 53-60 | |
| P577 | publication date | 2014-10-04 | |
| P1433 | published in | Current opinion in virology | Q26842394 |
| P1476 | title | Roseoloviruses in transplant recipients: clinical consequences and prospects for treatment and prevention trials | |
| P478 | volume | 9 |
| Q40120756 | Absence of human herpesvirus 6B detection in association with illness in children undergoing cancer chemotherapy |
| Q47133504 | Antibody Cross-Reactivity between Porcine Cytomegalovirus (PCMV) and Human Herpesvirus-6 (HHV-6). |
| Q40086447 | CD4+ T Cells Coexpressing CD134 (OX40) Harbor Significantly Increased Levels of Human Herpesvirus 6B DNA Following Umbilical Cord Blood Transplantation |
| Q91782357 | Chromatin Profiles of Chromosomally Integrated Human Herpesvirus-6A |
| Q35752239 | Coreactivation of Human Herpesvirus 6 and Cytomegalovirus Is Associated With Worse Clinical Outcome in Critically Ill Adults |
| Q36834718 | Detection of Human Herpesvirus 6B (HHV-6B) Reactivation in Hematopoietic Cell Transplant Recipients with Inherited Chromosomally Integrated HHV-6A by Droplet Digital PCR. |
| Q36689275 | Efficient identification of inherited chromosomally integrated human herpesvirus 6 using specimen pooling |
| Q51336180 | G-quadruplexes and G-quadruplex ligands: targets and tools in antiviral therapy. |
| Q91675180 | Genome-Wide Approach to the CD4 T-Cell Response to Human Herpesvirus 6B |
| Q92993210 | Guidelines from the 2017 European Conference on Infections in Leukaemia for management of HHV-6 infection in patients with hematologic malignancies and after hematopoietic stem cell transplantation |
| Q90369398 | Human herpesvirus 6 in transplant recipients: an update on diagnostic and treatment strategies |
| Q89621100 | Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple Sclerosis |
| Q38373988 | Outcomes of hematopoietic cell transplantation using donors or recipients with inherited chromosomally integrated HHV-6. |
| Q38280936 | Past, present, and future perspectives on the diagnosis of Roseolovirus infections. |
| Q59351012 | RNA sequencing of the i human herpesvirus 6B transcriptome to identify targets for clinical assays distinguishing between latent and active infections |
| Q38273230 | Roseolovirus molecular biology: recent advances |
| Q38704989 | Stabilization of Telomere G-Quadruplexes Interferes with Human Herpesvirus 6A Chromosomal Integration. |
Search more.